Caudle KE, Gammal RS, Whirl-Carrillo M, et al. Evidence and resources to implement pharmacogenetic knowledge for precision medicine. Am J Health Syst Pharm 2016;73:1977–1985.

• Crossref
• PubMed
Caudle KE, Gammal RS, Whirl-Carrillo M, Evidence and resources to implement pharmacogenetic knowledge for precision medicine. Am J Health Syst Pharm 2016;73:1977–1985.10.2146/ajhp15097727864205)| false
• Search Google Scholar
• Export Citation

Rakvåg TT, Klepstad P, Baar C, et al. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain 2005;116:73–78.

• Crossref
• PubMed
Rakvåg TT, Klepstad P, Baar C, The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain 2005;116:73–78.10.1016/j.pain.2005.03.03215927391)| false
• Search Google Scholar
• Export Citation

Drewe J, Ball HA, Beglinger C, et al. Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine. Br J Clin Pharmacol 2000;50:237–246.

• Crossref
• PubMed
Drewe J, Ball HA, Beglinger C, Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine. Br J Clin Pharmacol 2000;50:237–246.10.1046/j.1365-2125.2000.00226.x10971308)| false
• Search Google Scholar
• Export Citation

Mogil JS, Ritchie J, Smith SB, et al. Melanocortin-1 receptor gene variants affect pain and μ-opioid analgesia in mice and humans. J Med Genet 2005;42:583–587.

• Crossref
• PubMed
Mogil JS, Ritchie J, Smith SB, Melanocortin-1 receptor gene variants affect pain and μ-opioid analgesia in mice and humans. J Med Genet 2005;42:583–587.10.1136/jmg.2004.02769815994880)| false
• Search Google Scholar
• Export Citation

Lötsch J, Geisslinger G. Current evidence for a genetic modulation of the response to analgesics. Pain 2006;121:1–5.

• Crossref
• PubMed
Lötsch J, Geisslinger G. Current evidence for a genetic modulation of the response to analgesics. Pain 2006;121:1–5.10.1016/j.pain.2006.01.01016472919)| false
• Search Google Scholar
• Export Citation

U.S. Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labeling. Accessed April 12, 2022. Available at: https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling

• PubMed
U.S. Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labeling. Accessed April 12, 2022. Available at: https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling)| false
• Search Google Scholar
• Export Citation

Swarm RA, Youngwerth JM, Agne JL, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Adult Cancer Pain. Version 1.2022. Accessed April 12, 2022. Available at NCCN.org

• PubMed
Swarm RA, Youngwerth JM, Agne JL, NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Adult Cancer Pain. Version 1.2022. Accessed April 12, 2022. Available at NCCN.org)| false
• Search Google Scholar
• Export Citation

Lötsch J, Geisslinger G. Are μ-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol Med 2005; 11:82–89.

• Crossref
• PubMed
Lötsch J, Geisslinger G. Are μ-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol Med 2005; 11:82–89.10.1016/j.molmed.2004.12.00615694871)| false
• Search Google Scholar
• Export Citation

Coffman BL, Rios GR, King CD, et al. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 1997;25:1–4.

• PubMed
Coffman BL, Rios GR, King CD, Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 1997;25:1–4.9010622)| false
• Search Google Scholar
• Export Citation

Sanchez-Covarrubias L, Slosky LM, Thompson BJ, et al. P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac. PLoS One 2014;9:e88516.

• Crossref
• PubMed
Sanchez-Covarrubias L, Slosky LM, Thompson BJ, P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac. PLoS One 2014;9:e88516.2452039310.1371/journal.pone.0088516)| false
• Search Google Scholar
• Export Citation

Moody DE, Liu F, Fang, WB, et al. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism. J Anal Toxicol 2015;39:374–386.

• Crossref
• PubMed
Moody DE, Liu F, Fang, WB, Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism. J Anal Toxicol 2015;39:374–386.10.1093/jat/bkv03025868557)| false
• Search Google Scholar
• Export Citation

Charpiat B, Tod M, Darnis B, et al. Respiratory depression related to multiple drug–drug interactions precipitated by a fluconazole loading dose in a patient treated with oxycodone. Eur J Clin Pharmacol 2017;73: 787–788.

• Crossref
• PubMed
Charpiat B, Tod M, Darnis B, Respiratory depression related to multiple drug–drug interactions precipitated by a fluconazole loading dose in a patient treated with oxycodone. Eur J Clin Pharmacol 2017;73: 787–788.10.1007/s00228-017-2215-5)| false
• Search Google Scholar
• Export Citation